SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019717
Filing Date
2023-05-09
Accepted
2023-05-09 16:20:59
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20230331.htm   iXBRL 10-Q 2559331
2 EX-31.1 lbph-ex31_1.htm EX-31 22838
3 EX-31.2 lbph-ex31_2.htm EX-31 22881
4 EX-32.1 lbph-ex32_1.htm EX-32 22480
5 GRAPHIC img9514527_0.jpg GRAPHIC 56341
  Complete submission text file 0000950170-23-019717.txt   10028970

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20230331_lab.xml EX-101.LAB 412373
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20230331_def.xml EX-101.DEF 167412
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20230331_pre.xml EX-101.PRE 308435
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20230331.xsd EX-101.SCH 44318
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20230331_cal.xml EX-101.CAL 38724
54 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20230331_htm.xml XML 2338932
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 23902370
SIC: 2834 Pharmaceutical Preparations